欣旺達(300207.SZ):擬以13.46億元轉讓欣旺達汽車電池4.21%的股權
格隆匯2月8日丨欣旺達(300207.SZ)公佈,公司全資子公司欣旺達惠州新能源有限公司(“惠州新能源”)擬向浙江義欣動力電池有限公司(“浙江義欣”)、深圳紅土渝富新能源合夥企業(有限合夥)(“紅土渝富”)轉讓其持有的欣旺達電動汽車電池有限公司(“欣旺達汽車電池”)股權,擬轉讓股權比例合計4.21%、交易金額為134,575萬元人民幣。
上述出售欣旺達汽車電池部分股權所得資金,將用於補充公司日常經營所需資金或償還銀行貸款,支持公司業務的發展。
此次交易前,公司通過惠州新能源持有欣旺達汽車電池50.00%股權,交易完成後,公司持有欣旺達汽車電池45.79%股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.